EcoDrugPlus

Carbonic Anhydrase 2

Ensembl ID : ENSDNOG00000043973
Gene Symbol: CA2
4 Cross references
285 Possible Orthologues:

Carbonic Anhydrase 3

Ensembl ID : ENSDNOG00000044877
Gene Symbol: CA3
4 Cross references
310 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSDNOG00000042697
Gene Symbol: CA4
4 Cross references
334 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSDNOG00000041192
Gene Symbol: CA5A
4 Cross references
170 Possible Orthologues:

Carbonic Anhydrase 5b

Ensembl ID : ENSDNOG00000034929
Gene Symbol: CA5B
2 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSDNOG00000010140
Gene Symbol: CA6
2 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSDNOG00000019175
Gene Symbol: CA7
4 Cross references
221 Possible Orthologues:

Carbonic Anhydrase 9

Ensembl ID : ENSDNOG00000019791
Gene Symbol: CA9
4 Cross references
283 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSDNOG00000035425
Gene Symbol: CSNK1E
4 Cross references
264 Possible Orthologues:

Casein Kinase 2 Alpha 1

Ensembl ID : ENSDNOG00000034292
Gene Symbol: CSNK2A1
3 Cross references
138 Possible Orthologues:

Caspase 1

Ensembl ID : ENSDNOG00000010333
Gene Symbol: CASP1
3 Cross references
460 Possible Orthologues:

Caspase 8

Ensembl ID : ENSDNOG00000035172
Gene Symbol: CASP8
4 Cross references
132 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).